Related Experiment Video
Updated: Jan 28, 2026

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
Published on: September 8, 2023
[Giant pulmonary artery aneurysms. Case report and proposal of management algorithm]
A Radermecker1, L Stiennon1, A Leroux2
1Service de Chirurgie cardio-vasculaire et thoracique, CHU Liège, Belgique.
Pulmonary artery aneurysm (PAA) is a rare condition. A case report highlights a giant PAA associated with a dysplastic pulmonary valve, suggesting a congenital link and proposing a new diagnostic approach.
Area of Science:
- Cardiology
- Thoracic Surgery
- Medical Imaging
Background:
- Pulmonary artery aneurysm (PAA) is a rare condition with diverse causes and mechanisms.
- Homogenous sub-grouping is essential for effective medical and surgical management of PAAs.
- Understanding PAA etiology is crucial for patient outcomes.
Observation:
- A case of a giant PAA was observed without pulmonary hypertension.
- This giant PAA was associated with a dysplastic pulmonary valve.
- The co-occurrence suggests a potential congenital anomaly affecting pulmonary valve and root development.
Findings:
- The association of PAA with dysplastic pulmonary valve may stem from developmental abnormalities.
- Minor PAAs are often asymptomatic, but large aneurysms can cause life-threatening complications.
- Pulmonary valve insufficiency secondary to PAA can lead to right ventricular dysfunction.
Implications:
- This case highlights a specific PAA presentation and its potential congenital origins.
- A proposed diagnostic algorithm aims to improve nosologic classification and management strategies for PAAs.
- Further research into PAA subtypes and associated conditions is warranted for improved patient care.
Related Concept Videos
Aneurysm IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Peripheral Artery Disease V: Postoperative Nursing Management

